GENEVANT SCIENCES GMBH has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and biotechnology are BIOPHARMAGEN CORP FANGZHOU SUZHOU, ROCHE MADISON INC and FVG LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 2 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Biotechnology | |
#4 | Foods and drinks | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Special macromolecular compounds | |
#4 | Therapeutic chemical compounds | |
#5 | Enzymes | |
#6 | Animal care | |
#7 | Macromolecular compounds compositions |
# | Name | Total Patents |
---|---|---|
#1 | Galperin Anna | 7 |
#2 | Prieve Mary G | 7 |
#3 | Harvie Pierrot | 7 |
#4 | Roy Debashish | 7 |
#5 | Monahan Sean D | 7 |
#6 | Houston Jr Michael E | 5 |
#7 | Qabar Maher | 5 |
#8 | Declue Michael S | 5 |
#9 | Paschal Amber E | 5 |
#10 | Diab Charbel | 5 |
Publication | Filing date | Title |
---|---|---|
WO2021081420A2 | Conjugates and methods for treating acromegaly | |
WO2021081225A1 | Ornithine transcarbamylase (otc) constructs and methods of using the same | |
WO2020219941A1 | Lipid nanoparticles | |
WO2020093061A1 | Therapeutic methods |